Selective 20S proteasome inhibition for multiple myeloma therapy

Project description

Towards more selective treatments for mulitple myeloma

Fields of science

• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs
• natural sciences › biological sciences › biochemistry › biomolecules › proteins
• medical and health sciences › clinical medicine › oncology

Programme(s)

• H2020-EU.1.1. - EXCELLENT SCIENCE - European Research Council (ERC)

Topic(s)

• ERC-2018-PoC - ERC Proof of Concept Grant

Call for proposal

ERC-2018-PoC
See other projects for this call

Funding Scheme

ERC-POC - Proof of Concept Grant

Host institution

WEIZMANN INSTITUTE OF SCIENCE

Address

Herzl Street 234
7610001 Rehovot
Israel

Activity type

Higher or Secondary Education Establishments

Links

EU contribution

€ 150 000

Beneficiaries (1)

WEIZMANN INSTITUTE OF SCIENCE

Israel

EU contribution

€ 150 000

Address

Herzl Street 234
7610001 Rehovot

Activity type

Higher or Secondary Education Establishments

Links